ELISA Market Expands with Growing Applications in Oncology, Immunology, and Infectious Diseases
Growing pharmaceutical quality control requirements are encouraging the use of ELISA testing. Manufacturers are utilizing immunoassay techniques to analyze biological samples and support quality assessment during drug development and production.
Market Overview
The Enzyme-Linked Immunosorbent Assay (ELISA) Market was valued at US$ 2.47 billion in 2025 and is projected to reach US$ 4.13...